Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry.

PubWeight™: 1.99‹?› | Rank: Top 2%

🔗 View Article (PMID 22835555)

Published in Ann Thorac Surg on July 25, 2012

Authors

Usman Ahmad1, Zuoheng Wang, Ayesha S Bryant, Anthony W Kim, Jasleen Kukreja, David P Mason, Christian A Bermudez, Frank C Detterbeck, Daniel J Boffa

Author Affiliations

1: Section of Thoracic Surgery, Department of Epidemiology, Yale University School of Public Health, New Haven, Connecticut 06520-8062, USA.

Articles citing this

Lung transplantation for lung cancer. Ann Thorac Surg (2013) 1.07

Lung cancer: a rare indication for, but frequent complication after lung transplantation. J Thorac Dis (2016) 0.75

Reply: To PMID 22835555. Ann Thorac Surg (2013) 0.75

Articles by these authors

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

The new lung cancer staging system. Chest (2009) 6.30

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.82

Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med (2007) 3.39

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.39

Initial consecutive experience of completely portal robotic pulmonary resection with 4 arms. J Thorac Cardiovasc Surg (2011) 2.81

Intercostal muscle flap reduces the pain of thoracotomy: a prospective randomized trial. J Thorac Cardiovasc Surg (2005) 2.45

Results of a prospective algorithm to remove chest tubes after pulmonary resection with high output. J Thorac Cardiovasc Surg (2008) 2.39

The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis. Ann Thorac Surg (2011) 2.38

Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg (2006) 2.31

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.16

Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00

Intracostal sutures decrease the pain of thoracotomy. Ann Thorac Surg (2003) 1.97

Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94

Starting a robotic program in general thoracic surgery: why, how, and lessons learned. Ann Thorac Surg (2011) 1.84

Daily chest roentgenograms are unnecessary in nonhypoxic patients who have undergone pulmonary resection by thoracotomy. Ann Thorac Surg (2011) 1.72

A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69

The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg (2010) 1.69

The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg (2005) 1.63

The removal of chest tubes despite an air leak or a pneumothorax. Ann Thorac Surg (2009) 1.62

Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest (2012) 1.60

Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59

Management of subcutaneous emphysema after pulmonary resection. Ann Thorac Surg (2008) 1.59

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol (2004) 1.56

Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications. Ann Thorac Surg (2009) 1.56

The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: who returns to the surgical arena and who survives. Ann Thorac Surg (2008) 1.56

Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg (2007) 1.54

"Back to the future": recruiting the best and brightest into cardiothoracic surgery. J Thorac Cardiovasc Surg (2010) 1.53

Hydrogen preconditioning during ex vivo lung perfusion improves the quality of lung grafts in rats. Transplantation (2014) 1.51

Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension. J Heart Lung Transplant (2010) 1.51

Variant callers for next-generation sequencing data: a comparison study. PLoS One (2013) 1.50

Management of thoracic esophageal perforations. Eur J Cardiothorac Surg (2011) 1.50

Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.50

Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med (2014) 1.49

Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol (2009) 1.47

The benefits of continuous and digital air leak assessment after elective pulmonary resection: a prospective study. Ann Thorac Surg (2008) 1.46

Accidental insertion of a percutaneous venovenous cannula into the persistent left superior vena cava of a patient undergoing liver transplantation. Can J Anaesth (2011) 1.46

Hydrogen-supplemented drinking water protects cardiac allografts from inflammation-associated deterioration. Transpl Int (2012) 1.44

Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J (2012) 1.43

A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy? J Thorac Cardiovasc Surg (2005) 1.42

Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement. Biochem Biophys Res Commun (2012) 1.42

The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc (2014) 1.41

Functional mapping of quantitative trait loci underlying growth trajectories using a transform-both-sides logistic model. Biometrics (2004) 1.40

A comparison of association methods correcting for population stratification in case-control studies. Ann Hum Genet (2011) 1.40

Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39

How to teach robotic pulmonary resection. Semin Thorac Cardiovasc Surg (2013) 1.38

T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg (2007) 1.38

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37

A genome-wide association study on obesity and obesity-related traits. PLoS One (2011) 1.33

Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg (2009) 1.30

Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer. Ann Thorac Surg (2004) 1.30

Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest (2006) 1.27

Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative: a prospective study. Chest (2006) 1.27

Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg (2013) 1.24

The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg (2004) 1.24

Bridge to lung transplantation using short-term ambulatory extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg (2010) 1.21

The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer (2007) 1.21

The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol (2015) 1.20

Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Ann Thorac Surg (2008) 1.18

Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18

Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer. Ann Thorac Surg (2007) 1.18

Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax. Ann Thorac Surg (2006) 1.17

Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg (2005) 1.17

A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomized trial. Ann Thorac Surg (2008) 1.16

Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16

Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol (2011) 1.16

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12

Effect of sympathectomy level on the incidence of compensatory hyperhidrosis after sympathectomy for palmar hyperhidrosis. J Thorac Cardiovasc Surg (2009) 1.12

Fast tracking after Ivor Lewis esophagogastrectomy. Chest (2004) 1.11

Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg (2006) 1.11

An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 1.08

Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg (2006) 1.08

Lungs from donation after cardiac death for transplantation. Eur J Cardiothorac Surg (2013) 1.07

Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation. J Cyst Fibros (2011) 1.07

New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther (2009) 1.07

Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg (2008) 1.06

Malignant pleural effusion: one size does not fit all. Ann Thorac Surg (2013) 1.05

Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction. J Thorac Oncol (2009) 1.05

The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg (2003) 1.05

Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy? Ann Thorac Surg (2006) 1.04

Update on cardiothoracic surgery resident job opportunities. Ann Thorac Surg (2010) 1.04

Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg (2004) 1.04

Surgical techniques and results for partial or circumferential sleeve resection of the pulmonary artery for patients with non-small cell lung cancer. Ann Thorac Surg (2007) 1.03

Distribution and likelihood of lymph node metastasis based on the lobar location of nonsmall-cell lung cancer. Ann Thorac Surg (2006) 1.03

A prospective study to determine the incidence of non-imaged malignant pulmonary nodules in patients who undergo metastasectomy by thoracotomy with lung palpation. Ann Thorac Surg (2011) 1.03

Rigid bronchoscopy and surgical resection for broncholithiasis and calcified mediastinal lymph nodes. J Thorac Cardiovasc Surg (2008) 1.02

Lumping, splitting, and sorting. J Thorac Oncol (2007) 1.01

Malignant pleural mesothelioma. Curr Oncol Rep (2011) 1.01

Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res (2010) 1.01

Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol (2009) 1.01